Science & Technology
Design and optimization of TCR-T therapeutics by an advanced T cell receptor-antigen binding prediction platform
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41CA302099-01A1
Award Ceiling
$360K
Award Floor
$360K
Close Date
Aug 31, 2026
169 days leftTotal Funding
$360K
Expected Awards
1
Posted Date
Sep 18, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R41CA302099-01A1
Description
STTR Phase Phase I award: "Design and optimization of TCR-T therapeutics by an advanced T cell receptor-antigen binding prediction platform" awarded to NIGHTSTAR BIOTECHNOLOGIES, INC in HOUSTON, Texas. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $360,442. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, HUBZone businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.